Development of Antibodies to Human Thrombin and Factor V in a Patient Exposed to Topical Bovine Thrombin

被引:3
作者
Lo, Clara Y. [2 ]
Jones, Carol [1 ]
Glader, Bertil [2 ]
Zehnder, James L. [1 ,3 ]
机构
[1] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Med Hematol, Stanford, CA 94305 USA
关键词
coagulation; hematology; hemostasis and thrombosis; thrombotic disorders; INHIBITOR; COAGULOPATHY; SURGERY;
D O I
10.1002/pbc.22699
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bovine topical thrombin is commonly used for local hemostasis in pediatric surgery. Acquired inhibitors to coagulation factors, particularly to factor V and bovine thrombin, have been infrequently reported in the pediatric population. We report a 3-year-old male who developed a coagulopathy and clinical bleeding after cardio-thoracic surgery, during which bovine topical thrombin was used for local hemostasis. Laboratory tests revealed elevated prothrombin, partial thromboplastin, and thrombin times, and a low factor V activity level. He was found to have both human-thrombin and factor V inhibitors, among the first reported cases of these combined inhibitors secondary to bovine topical thrombin. He was treated with intravenous immunoglobulin and steroids with a rapid and durable response. Pediatr Blood Cancer. 2010;55:1195-1197. (C) 2010 wiley-Liss, Inc.
引用
收藏
页码:1195 / 1197
页数:3
相关论文
共 14 条
[1]  
BANNINGER H, 1993, BRIT J HAEMATOL, V85, P528
[2]   Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin [J].
Crow, Sheri S. ;
Sullivan, Vita V. ;
Aysola, Agnes E. ;
Key, Nigel S. ;
Harker-Murray, Paul ;
Foker, John E. ;
Steiner, Marie E. .
ANNALS OF THORACIC SURGERY, 2007, 83 (04) :1547-1549
[3]   COAGULOPATHY DUE TO AN ACQUIRED FACTOR-V INHIBITOR AND SUBSEQUENTLY THROMBOSIS [J].
GEORGE, S ;
NAGABHUSHANA, MS ;
CYRAN, EM .
AMERICAN JOURNAL OF HEMATOLOGY, 1995, 49 (01) :98-100
[4]   Recent developments in topical thrombins [J].
Kessler, Craig M. ;
Ortel, Thomas L. .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (01) :15-24
[5]   INHIBITOR TO FACTOR-V AFTER EXPOSURE TO FIBRIN SEALANT DURING CARDIAC-SURGERY IN A 2-YEAR-OLD CHILD [J].
MUNTEAN, W ;
ZENZ, W ;
FINDING, K ;
ZOBEL, G ;
BEITZKE, A .
ACTA PAEDIATRICA, 1994, 83 (01) :84-87
[6]  
Ness P, 2009, PATIENT SAF SURG, V3, DOI 10.1186/1754-9493-3-8
[7]   Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin [J].
Ortel, TL ;
Mercer, MC ;
Thames, EH ;
Moore, KD ;
Lawson, JH .
ANNALS OF SURGERY, 2001, 233 (01) :88-96
[8]   CLINICAL-SIGNIFICANCE OF ANTIBODIES TO BOVINE AND HUMAN THROMBIN AND FACTOR-V AFTER SURGICAL USE OF BOVINE THROMBIN [J].
RAPAPORT, SI ;
ZIVELIN, A ;
MINOW, RA ;
HUNTER, CS ;
DONNELLY, K .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1992, 97 (01) :84-91
[9]   Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure [J].
Savage, William J. ;
Kickler, Thomas S. ;
Takemoto, Clifford M. .
PEDIATRIC BLOOD & CANCER, 2007, 49 (07) :1025-1029
[10]   BOVINE THROMBIN-INDUCED INHIBITOR OF FACTOR-V AND BLEEDING RISK IN POSTOPERATIVE NEUROSURGICAL PATIENTS - REPORT OF 3 CASES [J].
SPERO, JA .
JOURNAL OF NEUROSURGERY, 1993, 78 (05) :817-820